SE0401716D0 - New compounds - Google Patents
New compoundsInfo
- Publication number
- SE0401716D0 SE0401716D0 SE0401716A SE0401716A SE0401716D0 SE 0401716 D0 SE0401716 D0 SE 0401716D0 SE 0401716 A SE0401716 A SE 0401716A SE 0401716 A SE0401716 A SE 0401716A SE 0401716 D0 SE0401716 D0 SE 0401716D0
- Authority
- SE
- Sweden
- Prior art keywords
- new compounds
- active compounds
- compounds
- new
- therapy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401716A SE0401716D0 (sv) | 2004-07-02 | 2004-07-02 | New compounds |
| PCT/SE2005/001033 WO2006004507A2 (en) | 2004-07-02 | 2005-06-29 | New benzothiazole derivatives useful for treating cns disorders |
| US11/571,184 US20110098292A1 (en) | 2004-07-02 | 2005-06-29 | New Compounds Useful for Treating CNS Disorders |
| JP2007519164A JP2008505070A (ja) | 2004-07-02 | 2005-06-29 | Ｃｎｓ障害の治療に有用な新規化合物 |
| EP05754887A EP1765815A2 (en) | 2004-07-02 | 2005-06-29 | New compounds useful for treating cns disorders |
| CNA200580022443XA CN1980922A (zh) | 2004-07-02 | 2005-06-29 | 用于治疗cns病症的新苯并噻唑衍生物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401716A SE0401716D0 (sv) | 2004-07-02 | 2004-07-02 | New compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0401716D0 true SE0401716D0 (sv) | 2004-07-02 |
Family
ID=32733741
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0401716A SE0401716D0 (sv) | 2004-07-02 | 2004-07-02 | New compounds |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20110098292A1 (sv) |
| EP (1) | EP1765815A2 (sv) |
| JP (1) | JP2008505070A (sv) |
| CN (1) | CN1980922A (sv) |
| SE (1) | SE0401716D0 (sv) |
| WO (1) | WO2006004507A2 (sv) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5128603B2 (ja) * | 2006-10-04 | 2013-01-23 | エフ．ホフマン−ラ ロシュ アーゲー | フェノキシジアミノピリミジン誘導体の合成方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002044174A2 (en) * | 2000-12-01 | 2002-06-06 | Bristol-Myers Squibb Pharma Company | 3-(2,4-dimethylthiazol-5-yl) indeno[1,2-c]pyrazol-4-one derivatives as cdk inhibitors |
| CA2506796A1 (en) * | 2002-11-25 | 2004-06-10 | Pharmacia Corporation | Heteroarylsulfonylmethyl hydroxamic acids and amides and their use as protease inhibitors |
-
2004
- 2004-07-02 SE SE0401716A patent/SE0401716D0/sv unknown
-
2005
- 2005-06-29 US US11/571,184 patent/US20110098292A1/en not_active Abandoned
- 2005-06-29 JP JP2007519164A patent/JP2008505070A/ja active Pending
- 2005-06-29 CN CNA200580022443XA patent/CN1980922A/zh active Pending
- 2005-06-29 EP EP05754887A patent/EP1765815A2/en not_active Withdrawn
- 2005-06-29 WO PCT/SE2005/001033 patent/WO2006004507A2/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| US20110098292A1 (en) | 2011-04-28 |
| CN1980922A (zh) | 2007-06-13 |
| JP2008505070A (ja) | 2008-02-21 |
| WO2006004507A2 (en) | 2006-01-12 |
| EP1765815A2 (en) | 2007-03-28 |
| WO2006004507A3 (en) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0200979D0 (sv) | New compounds | |
| TW200745111A (en) | New compounds | |
| TW200510375A (en) | New compounds | |
| SE0100569D0 (sv) | New compounds | |
| TW200606164A (en) | New compounds | |
| NO20070224L (no) | 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav | |
| SE0301700D0 (sv) | Novel compounds | |
| TW200745122A (en) | New compounds I | |
| ECSP088974A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| BRPI0514738A (pt) | derivados de amida de 3-fenil-diidropirimido[4,5-d]pirimidinonas, sua fabricação e aplicação como agentes farmacêuticos | |
| UA115131C2 (uk) | Сполуки боронатного ефіру і його фармацевтичні рецептури | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| ECSP088973A (es) | Derivados de imidazol pirimidina para el tratamiento de enfermedades relacionadas con la glicógeno sintasa quinasa (gsk3) | |
| SE0401762D0 (sv) | Novel compounds | |
| DE502005008057D1 (de) | Substituierte cyclopenten-verbindungen | |
| TW200716529A (en) | New compounds II | |
| TW200800984A (en) | New compounds | |
| MXPA05012247A (es) | Derivados de bencimidazol nuevos. | |
| CY1109366T1 (el) | Υποκατεστημενες ενωσεις 1,4,8-τριαζασπειρο[4.5]δεκαν-2-ονης | |
| MX2009010165A (es) | Nuevas imidazo[4,5-b]piridina-7-carboxamidas 704. | |
| TW200639156A (en) | New compounds | |
| SE0302546D0 (sv) | New compounds | |
| TW200640465A (en) | New pharmaceutically active compounds for the treatment of respiratory diseases | |
| SE0102440D0 (sv) | New compound | |
| TW200745133A (en) | New compounds II |